NORTH CHICAGO, Ill.,
June 2, 2021 /PRNewswire/
-- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs
42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021. Michael Severino, M.D., vice chairman and
president, Robert A. Michael,
executive vice president and chief financial officer, and
Jeffrey R. Stewart, executive vice
president, commercial operations, will present virtually at
8:40 a.m. Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram,
YouTube and LinkedIn.